SCHEMBL14083947

SCHEMBL14083947

CN(C)c1cccc(NC(=O)c2ccc(-c3ncccc3Cl)cn2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CSF1R P07333 1/20 0.49
▸ ATR Q13535 1/20 0.48
▸ TRPV1 Q8NER1 4/20 0.47
▸ SIRT1 Q96EB6 1/20 0.45
▸ SMN1; SMN2 Q16637 3/20 0.45
▸ MAPT P10636 3/20 0.45
▸ MEN1 O00255 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ BRAF P15056 1/20 0.43
▸ ALDH1A1 P00352 3/20 0.43
▸ LMNA P02545 2/20 0.43
▸ POLB P06746 1/20 0.43
▸ HIF1A Q16665 1/20 0.43
▸ GRM4 Q14833 1/20 0.43
▸ HDAC6 Q9UBN7 1/20 0.43
▸ NPC1 O15118 1/20 0.41
▸ GAA P10253 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ RECQL P46063 1/20 0.41
▸ RAB9A P51151 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14083535 0.88 TRPV1 (0.62) CSF1RATRTRPV1SIRT1SMN1; SMN2
SCHEMBL14083913 0.85 GRM4 (0.60) TRPV1SMN1; SMN2MAPTMEN1KMT2A
SCHEMBL14083584 0.83 TRPV1 (0.50) CSF1RATRTRPV1SIRT1SMN1; SMN2
SCHEMBL14083925 0.83 TRPV1 (0.47) CSF1RTRPV1SMN1; SMN2MAPTMEN1
SCHEMBL14083930 0.83 GRM4 (0.62) CSF1RTRPV1SMN1; SMN2MAPTMEN1
SCHEMBL14083912 0.82 TRPV1 (0.56) TRPV1ALDH1A1HIF1AGRM4NPC1
SCHEMBL14083054 0.82 P4HTM (0.50) TRPV1SMN1; SMN2MEN1KMT2AALDH1A1
SCHEMBL14084028 0.82 GRM4 (0.50) TRPV1SMN1; SMN2MAPTMEN1KMT2A
SCHEMBL14084034 0.81 GRM4 (0.48) TRPV1SMN1; SMN2MAPTMEN1KMT2A
SCHEMBL14083968 0.81 TRPV1 (0.49) TRPV1GRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof TRPV1, TRPA1, TRPV2 CSF1R 2217/4885ATR 3302/4885TRPV1 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback